Sign in

CIK 0001802665 · Large accelerated filer

Harmony Biosciences Holdings, Inc.

Sign in to watch
Ticker
HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822279923
Phone
(484) 539-9800
Business address
630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,108,586
in 2 filings

Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Budur Kumar −$3.1M CHIEF MEDICAL OFFICER sold 85% of stake

Reading 87 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-11-01 Dayno Jeffrey M. CHIEF MEDICAL OFFICER Option exercise +15,000 $8.22 $123K 15,000
2022-11-01 Dayno Jeffrey M. CHIEF MEDICAL OFFICER Sale −15,000 $55.10 $827K 0
2022-11-01 Dayno Jeffrey M. CHIEF MEDICAL OFFICER Option exercise · Stock Option −15,000 38,470
2022-10-03 Dierks Jeffrey CHIEF COMMERCIAL OFFICER Option exercise +12,173 $8.22 $100K 12,173
2022-10-03 Dierks Jeffrey CHIEF COMMERCIAL OFFICER Sale −9,382 $44.45 $417K 2,791
2022-10-03 Dierks Jeffrey CHIEF COMMERCIAL OFFICER Sale −2,791 $45.47 $127K 0
2022-10-03 Dierks Jeffrey CHIEF COMMERCIAL OFFICER Option exercise · Stock Option −9,739 0
2022-10-03 Dierks Jeffrey CHIEF COMMERCIAL OFFICER Option exercise · Stock Option −2,434 2,435

Page 14 of 14 · 268 trades